Impact of body mass index on estradiol depletion by aromatase inhibitors in postmenopausal women with early breast cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of body mass index on estradiol depletion by aromatase inhibitors in postmenopausal women with early breast cancer
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 109, Issue 6, Pages 1522-1527
Publisher
Springer Nature
Online
2013-09-04
DOI
10.1038/bjc.2013.499
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Patient's Anastrozole Compliance to Therapy (PACT) Program: a randomized, in-practice study on the impact of a standardized information program on persistence and compliance to adjuvant endocrine therapy in postmenopausal women with early breast cancer†
- (2013) P. Hadji et al. ANNALS OF ONCOLOGY
- Persistence in patients with breast cancer treated with tamoxifen or aromatase inhibitors: a retrospective database analysis
- (2013) P. Hadji et al. BREAST CANCER RESEARCH AND TREATMENT
- The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial
- (2013) M Gnant et al. BRITISH JOURNAL OF CANCER
- Obesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 Trial
- (2012) Marianne Ewertz et al. JOURNAL OF CLINICAL ONCOLOGY
- Suppression of Plasma Estrogen Levels by Letrozole and Anastrozole Is Related to Body Mass Index in Patients With Breast Cancer
- (2012) Elizabeth J. Folkerd et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of Body Mass Index on the Efficacy of Endocrine Therapy in Premenopausal Patients With Breast Cancer: An Analysis of the Prospective ABCSG-12 Trial
- (2011) Georg Pfeiler et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis
- (2010) Melinda Protani et al. BREAST CANCER RESEARCH AND TREATMENT
- Estrogen Negative Feedback on Gonadotropin Secretion: Evidence for a Direct Pituitary Effect in Women
- (2010) N. D. Shaw et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer
- (2010) Harold J. Burstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of Body Mass Index on Recurrences in Tamoxifen and Anastrozole Treated Women: An Exploratory Analysis From the ATAC Trial
- (2010) Ivana Sestak et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of Obesity on Prognosis After Early-Stage Breast Cancer
- (2010) Marianne Ewertz et al. JOURNAL OF CLINICAL ONCOLOGY
- The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial
- (2009) Evandro de Azambuja et al. BREAST CANCER RESEARCH AND TREATMENT
- Obesity and Cancer: The Role of Dysfunctional Adipose Tissue
- (2009) R. C.M. van Kruijsdijk et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Improving compliance and persistence to adjuvant tamoxifen and aromatase inhibitor therapy
- (2009) Peyman Hadji CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Adherence to Initial Adjuvant Anastrozole Therapy Among Women With Early-Stage Breast Cancer
- (2008) Ann H. Partridge et al. JOURNAL OF CLINICAL ONCOLOGY
- Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
- (2008) Andrew G Renehan et al. LANCET
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now